Fulcrum Therapeutics Inc (NAS:FULC)
$ 4.79 -0.05 (-1.03%) Market Cap: 258.37 Mil Enterprise Value: 12.97 Mil PE Ratio: 0 PB Ratio: 1.00 GF Score: 50/100

Q1 2020 Fulcrum Therapeutics Inc Earnings Call Transcript

May 13, 2020 / 12:00PM GMT
Release Date Price: $16.48 (+10.53%)
Operator

Good morning. And welcome to Fulcrum Therapeutics First Quarter 2020 Conference Call. (Operator Instructions)

I would now like to turn the call over to Christi Waarich, Director of Investor Relations and Corporate Communications at Fulcrum. Please proceed.

Christi Waarich
Fulcrum Therapeutics, Inc. - Director, Corporate Communications & IR

Thank you, Dimitria. Good morning. And welcome to the Fulcrum Therapeutics conference call to discuss our first quarter 2020 financial results and recent corporate highlights. Earlier today, we issued a press release outlining our recent progress. For those of you who don't have a copy, you can access it in the Investor Relations section of our website fulcrumtx.com.

Please be reminded that remarks made during this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development time lines and financial projections. While these forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot